CompletedNCT02090634
This study exists to see whether psychoeducation, a guided learning and support program, is workable and worth testing more broadly. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can better prevent setbacks and support longer-term stability.
BipolarityOtherOver 18 Years
- Countries
- United States
- Sponsor
- University of California, San Diego
- Condition
- Bipolarity
CompletedNCT02188732
This study exists to see whether smoking support or smoking-related treatment can play a useful role in care. Researchers are trying to understand whether smoking support or smoking-related treatment can better prevent setbacks and support longer-term stability.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Condition
- Schizophrenia
CompletedNCT02082678
This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
BipolarityOtherFrom 18 Years to 70 Years
- Countries
- United States
- Sponsor
- University of Texas Southwestern Medical Center
- Condition
- Bipolarity
TerminatedNCT04251234
This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.
BipolarityOtherFrom 18 Years to 45 Years
- Countries
- United States
- Sponsor
- University of Michigan
- Condition
- Bipolarity
CompletedNCT04068467
This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. For people living with Schizophrenia, that matters because support often needs to fit around real routines and access barriers.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- University of Washington
- Condition
- Schizophrenia
WithdrawnNCT04245696
This study exists to understand whether this type of care is both safe enough and useful enough to take further. Researchers are trying to understand whether this type of care can give earlier or clearer feedback during care.
BipolarityOtherFrom 21 Years to 70 Years
- Countries
- United States
- Sponsor
- Candela Corporation
- Condition
- Bipolarity
CompletedNCT03730064
This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand what brain scans or other body measurements can reveal about signals in the brain or body that may guide care later on.
BipolarityOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- Martin Lan
- Condition
- Bipolarity
CompletedNCT01976975
This study exists to explore whether questionnaires and follow-up reports could improve care and understanding. Researchers are trying to understand what questionnaires and follow-up reports can reveal about signals in the brain or body that may guide care later on.
DepressionOtherFrom 18 Years to 50 Years
- Countries
- United States
- Sponsor
- Mclean Hospital
- Condition
- Depression
CompletedNCT02363738
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.
BipolarityOtherFrom 18 Years to 65 Years
- Countries
- Canada, United States
- Sponsor
- University Health Network, Toronto
- Condition
- Bipolarity
TerminatedNCT02075047
This study exists to explore whether the medication Flexible could improve care and understanding. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.
BipolarityOtherFrom 10 Years to 17 Years
- Countries
- Ukraine, United States
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Condition
- Bipolarity
TerminatedNCT03768726
This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
BipolarityOtherFrom 10 Years to 17 Years
- Countries
- United States
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Condition
- Bipolarity
CompletedNCT02773420
This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can better support energy, concentration, and everyday functioning.
BipolarityOtherOver 18 Years
- Countries
- United States
- Sponsor
- University of Illinois at Chicago
- Condition
- Bipolarity
CompletedNCT03822416
This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand whether smoking support or smoking-related treatment can give earlier or clearer feedback during care.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- University of Minnesota
- Condition
- Depression
CompletedNCT02974010
This study exists to understand how acceptance and commitment therapy, a talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can better prevent setbacks and support longer-term stability.
BipolarityOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- NeuroRx, Inc.
- Condition
- Bipolarity
CompletedNCT00666432
This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.
BipolarityOtherOver 15 Years
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
- Condition
- Bipolarity
CompletedNCT01948024
This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 80 Years
- Countries
- United States
- Sponsor
- Sun Pharmaceutical Industries Limited
- Condition
- Schizophrenia
CompletedNCT00312494
This study exists to understand whether this type of care is both safe enough and useful enough to take further. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.
BipolarityOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Condition
- Bipolarity
CompletedNCT00282464
This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
BipolarityOtherOver 18 Years
- Countries
- United States
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Condition
- Bipolarity
CompletedNCT03050853
This study exists to see whether smoking support or smoking-related treatment can make care clearer and more responsive. Researchers are trying to understand whether smoking support or smoking-related treatment can work better when mental health difficulties overlap with substance use.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Condition
- Schizophrenia
CompletedNCT00141271
This study exists to understand whether this type of care is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.
BipolarityOtherOver 18 Years
- Countries
- United States
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Condition
- Bipolarity
CompletedNCT00265330
This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.
BipolarityOtherFrom 10 Years to 17 Years
- Countries
- United States
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Condition
- Bipolarity
CompletedNCT00280566
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.
BipolarityOtherOver 18 Years
- Countries
- Chile, France, Germany, Guatemala, China, India, Italy, Mexico, Russian Federation, Spain, Taiwan, United States, Venezuela
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Condition
- Bipolarity
TerminatedNCT00055575
This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
DepressionOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- National Institute of Mental Health (NIMH)
- Condition
- Depression
CompletedNCT01431573
This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve sleep, daily rhythms, and longer-term stability.
DepressionOtherFrom 18 Years to 75 Years
- Countries
- United States
- Sponsor
- New York State Psychiatric Institute
- Condition
- Depression
CompletedNCT00483548
This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.
BipolarityOtherOver 18 Years
- Countries
- Australia, India, United States
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Condition
- Bipolarity